CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
Condition(s):Hematologic Diseases; NeoplasmsLast Updated:April 25, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Hematologic Diseases; NeoplasmsLast Updated:April 25, 2023Recruiting
Condition(s):Benign and Malignant Hematologic DiseasesLast Updated:May 24, 2018Active, not recruiting
Condition(s):Coronavirus Infection and Hematologic DiseasesLast Updated:January 26, 2023Completed
Condition(s):Anemia, Sickle CellLast Updated:July 11, 2013Terminated
Condition(s):Angiodysplasia; Hematological DiseaseLast Updated:September 28, 2023Not yet recruiting
Condition(s):Hematologic Diseases; Bacteremia SepsisLast Updated:October 14, 2019Completed
Condition(s):Multiple Myeloma; Myeloma, Multiple; Myelomas, Multiple; Acute Myeloid Leukemia; Leukemias, Acute Myeloid; Myeloid Leukemias, Acute; Hemophilia; Hemophilia A; Hemophilia As; Hemophilia B; Hemophilia Bs; Myelodysplastic Syndrome; MDS; Lymphoma; Leukemia; Aplastic Anemia; Bleeding Disorder; Bone Marrow Transplantation; Blood Disease InfectionLast Updated:April 25, 2023Recruiting
Condition(s):Haematologic Disease; Haematological MalignancyLast Updated:September 15, 2023Recruiting
Condition(s):Hematopoietic Stem Cell Transplantation; Malignant Hematological DiseasesLast Updated:July 6, 2023Recruiting
Condition(s):Hematological Diseases; Carbapenem-resistant Enterobacteriaceae; Carbapenem-resistant Pseudomonas Aeruginosa; Carbapenem-resistant Acinetobacter BaumanniiLast Updated:August 12, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.